Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

July 29, 2019July 29, 2019

CHMP Favors Approving Stelara to Treat Moderate to Severe Ulcerative Colitis in EU

News

The Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency (EMA), has recommended that Stelara (ustekinumab) be approved in Europe to treat moderately to severely active ... Read more

July 26, 2019July 26, 2019

Hadlima, Biosimilar to Humira, Receives FDA Approval to Treat Autoimmune Diseases

News

Hadlima (adalimumab-bwwd) — an antibody biosimilar to AbbVie‘s Humira (adalimumab) — has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of a number of autoimmune ... Read more

July 22, 2019July 22, 2019

Remicade Biosimilar CT-P13 Found Safe, Effective for IBD Treatment in Italian Study

News

CT-P13, a biosimilar of Remicade (infliximab), is safe and effective for the treatment of inflammatory bowel disease (IBD), a study suggests. The study, “Infliximab biosimilar CT-P13 is effective and safe ... Read more

July 19, 2019July 19, 2019

Gene Expression Grouping Can Predict Treatment Response in Ulcerative Colitis, Study Suggests

News

People with ulcerative colitis can be divided into groups based on gene expression, and this division can help identify those more likely to respond to treatments, a recent study found. ... Read more

July 16, 2019July 16, 2019

Study Links Etanercept with Increased IBD Risk

News

Treatment with etanercept may increase a person’s risk of developing inflammatory bowel disease (IBD), a study suggests. The study, “Increased risk of developing Crohn’s disease or ulcerative colitis in 17 ... Read more

July 10, 2019July 10, 2019

Study Links Depression to Increased IBD Activity, Faulty Emotional Recognition

News

Depression is linked to increased disease activity and fewer positive emotional recognition biases in people with inflammatory bowel disease (IBD), a study suggests. The study, “Factors associated with depression in ... Read more

June 28, 2019June 28, 2019

Sunshine May Lower Risk of IBD in Children, Study Suggests

News

Children who are exposed to more sunshine may be less likely to develop inflammatory bowel disease (IBD), a study suggests. The study, titled “Higher Sun Exposure is Associated With Lower ... Read more

June 19, 2019June 19, 2019

Innovation Pharmaceuticals Signs Deal to Use Tablet Technology for Oral Brilacidin Treatment

News

Innovation Pharmaceuticals has signed an agreement to use OralogiK — an advanced tablet-coating technology patented by BDD Pharma — to develop tablets for targeted oral delivery of Brilacidin for treating ... Read more

June 17, 2019June 17, 2019

Nine-Month Results Show Continuing Efficacy of Abivax’s ABX464 in Extension Trial

News

Treatment with Abivax‘s ABX464 showed continuing effectiveness in ulcerative colitis patients, according to nine-month data of a maintenance clinical trial. The company is now recruiting people with moderate-to-severe ulcerative colitis ... Read more